EW vs LEN · P/E 47, rev $1.39B vs rev $34.19B
Edwards Lifesciences Corp (EW) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
LEN (LEN) common stock.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
EW currently screens at market cap $49.91B and trailing P/E 46.9. LEN currently screens at market cap $0.
Not investment advice. Open the EW and LEN stock pages for the full models.
Not investment advice.